Funded Tech Companies
Cerevance
Wondering who invested in Cerevance? GV, Agent Capital and Double Point Ventures joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Cerevance
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Marina Park Dr. 1410
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Cerevance is a neuroscience company focused on discovering and developing novel therapeutics for neurological and psychiatric disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/25/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brad Margus
Chief Financial Officer
Robert Middlebrook
Chief Scientific Officer
Mark Carlton
Chief Scientific Officer
Nathaniel Heintz
Vice President
Roland Bürli
Vice President
Lee Dawson
Vice President
David Margolin
VP - Bus. Development
Ted Hibben
Company Investors
- GV (David Schenkein)
- Agent Capital (Campbell Murray)
- Double Point Ventures
- Gates Frontier Fund
- Bioluminescence Ventures (Kouki Harasaki)
- Lightstone Ventures
- Takeda Ventures (Mark Carlton)
- UPMC Enterprises
- Dementia Discovery Fund (Tetsuyuki Maruyama)
- Foresite Capital
- Dolby Family Ventures
- UPMC Health Plan (Matthias Kleinz)
- Casdin Capital
- Private Investors (William Gates)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs